Campyvax Campylobacter vaccine: Phase II

ANX said data from a double-blind, placebo-controlled U.S. Phase II trial in 25 healthy adults showed a 4-dose regimen of its Campylobacter vaccine gave a significant immune response, with a 10-fold i...